In summary, this study demonstrated that the long-term administration of aFGF facilitated a marked increase in SC proliferation and migration, and suppressed SC apoptosis to ameliorate disordered demyelination in T2DM mouse model. The gene discussed is FGF1; the disease is type 2 diabetes mellitus.